Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Levy

Showing results (241-250 of 571) with videos related to

Pageof 58
Sort By:
Multiple Sclerosis and Related Disorders|September 22, 2023
Are we there yet? The holy grail: A biomarker for Multiple SclerosisJeannette Lechner-Scott, Vicki Maltby, Gavin Giovannoni, et al.
Multiple Sclerosis and Related Disorders|December 3, 2024
Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosisGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|June 17, 2021
Probing the association between Multiple Sclerosis and Epstein Barr Virus from a therapeutic perspectiveNatalia Drosu, Gavin Giovannoni, Daniela Pohl, et al.
Multiple Sclerosis and Related Disorders|March 2, 2023
Are we ready for CD19-targeted CAR T-cell therapies in MS?Gavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|August 27, 2023
CNS resilience in the progression of MSGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|June 9, 2026
A new HANDling of progressive MS and progressive MS trialsGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|June 17, 2022
Multiple sclerosis is one diseaseGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Environmental Research|March 16, 2004
Childhood urine mercury excretion: dental amalgam and fish consumption as exposure factorsMichael Levy, Stephane Schwartz, Margareta Dijak, et al.
Multiple Sclerosis and Related Disorders|December 17, 2018
Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatmentAditya Banerjee, Jennifer Ng, Jessica Coleman, et al.
Multiple Sclerosis and Related Disorders|December 17, 2023
Emboldened or not: The potential fall-out of a failed anti-EBV trial in multiple sclerosisGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Pageof 58

Showing results (241-250 of 571) with videos related to

Sort By:
Pageof 58
Multiple Sclerosis and Related Disorders|September 22, 2023
Are we there yet? The holy grail: A biomarker for Multiple SclerosisJeannette Lechner-Scott, Vicki Maltby, Gavin Giovannoni, et al.
Multiple Sclerosis and Related Disorders|December 3, 2024
Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosisGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|June 17, 2021
Probing the association between Multiple Sclerosis and Epstein Barr Virus from a therapeutic perspectiveNatalia Drosu, Gavin Giovannoni, Daniela Pohl, et al.
Multiple Sclerosis and Related Disorders|March 2, 2023
Are we ready for CD19-targeted CAR T-cell therapies in MS?Gavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|August 27, 2023
CNS resilience in the progression of MSGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|June 9, 2026
A new HANDling of progressive MS and progressive MS trialsGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders|June 17, 2022
Multiple sclerosis is one diseaseGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Environmental Research|March 16, 2004
Childhood urine mercury excretion: dental amalgam and fish consumption as exposure factorsMichael Levy, Stephane Schwartz, Margareta Dijak, et al.
Multiple Sclerosis and Related Disorders|December 17, 2018
Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatmentAditya Banerjee, Jennifer Ng, Jessica Coleman, et al.
Multiple Sclerosis and Related Disorders|December 17, 2023
Emboldened or not: The potential fall-out of a failed anti-EBV trial in multiple sclerosisGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.
Pageof 58